Thc Therapeutics Stock Short Ratio
| THCT Stock | USD 0.0003 0.00 0.00% |
THC Therapeutics fundamentals help investors to digest information that contributes to THC Therapeutics' financial success or failures. It also enables traders to predict the movement of THC Pink Sheet. The fundamental analysis module provides a way to measure THC Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to THC Therapeutics pink sheet.
THC |
THC Therapeutics Company Short Ratio Analysis
THC Therapeutics' Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, THC Therapeutics has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and about the same as Health Care (which currently averages 0.0) industry. The short ratio for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Portfolio Holdings Now
Portfolio HoldingsCheck your current holdings and cash postion to detemine if your portfolio needs rebalancing |
| All Next | Launch Module |
THC Fundamentals
| Return On Asset | -5.57 | |||
| Current Valuation | 1.57 M | |||
| Shares Outstanding | 34.15 M | |||
| Shares Owned By Insiders | 30.84 % | |||
| Price To Earning | 1.25 X | |||
| Price To Book | 46.07 X | |||
| EBITDA | (1.06 M) | |||
| Net Income | (1.89 M) | |||
| Cash And Equivalents | 3.82 K | |||
| Total Debt | 925.89 K | |||
| Debt To Equity | 18.70 % | |||
| Current Ratio | 0.01 X | |||
| Book Value Per Share | (0.15) X | |||
| Cash Flow From Operations | (388.48 K) | |||
| Earnings Per Share | (0.09) X | |||
| Beta | 1.71 | |||
| Market Capitalization | 1.09 M | |||
| Total Asset | 480.07 K | |||
| Z Score | -6.0 | |||
| Net Asset | 480.07 K |
About THC Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze THC Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of THC Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of THC Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for THC Pink Sheet Analysis
When running THC Therapeutics' price analysis, check to measure THC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy THC Therapeutics is operating at the current time. Most of THC Therapeutics' value examination focuses on studying past and present price action to predict the probability of THC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move THC Therapeutics' price. Additionally, you may evaluate how the addition of THC Therapeutics to your portfolios can decrease your overall portfolio volatility.